80 FR 78737 - Agency Forms Undergoing Paperwork Reduction Act Review

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 80, Issue 242 (December 17, 2015)

[Federal Register Volume 80, Number 242 (Thursday, December 17, 2015)]
[Notices]
[Pages 78737-78738]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-31706]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-16-0009]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) has submitted 
the following information collection request to the Office of 
Management and Budget (OMB) for review and approval in accordance with 
the Paperwork Reduction Act of 1995. The notice for the proposed 
information collection is published to obtain comments from the public 
and affected agencies.
    Written comments and suggestions from the public and affected 
agencies concerning the proposed collection of information are 
encouraged. Your comments should address any of the following: (a) 
Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the agency, including 
whether the information will have practical utility; (b) Evaluate the 
accuracy of the agencies estimate of the burden of the proposed 
collection of information, including the validity of the methodology 
and assumptions used; (c) Enhance the quality, utility, and clarity of 
the information to be collected; (d) Minimize the burden of the 
collection of information on those who are to respond, including 
through the use of appropriate automated, electronic, mechanical, or 
other technological collection techniques or other forms of information 
technology, e.g., permitting electronic submission of responses; and 
(e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570 or send an email to [email protected]. Written comments and/or 
suggestions regarding the items contained in this notice should be 
directed to the Attention: CDC Desk Officer, Office of Management and 
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written 
comments should be received within 30 days of this notice.

[[Page 78738]]

Proposed Project

National Disease Surveillance Program-I--Case Reports--Revision--
National Center for Emerging and Zoonotic Infectious Disease (NCEZID), 
Centers for Disease Control and Prevention (CDC)

Background and Brief Description

    Surveillance of the incidence and distribution of disease has been 
an important function of the US Public Health Service (PHS) since an 
1878 Act of Congress, which authorized the PHS to collect morbidity 
reports. After the Malaria Control in War Areas Program had fulfilled 
its original 1942 objective of reducing malaria transmission, its basic 
tenets were carried forward and broadened by the formation of the 
Communicable Disease Center (CDC) in 1946. CDC was conceived of as a 
well-equipped, broadly staffed agency used to translate facts about 
analysis of morbidity and mortality statistics on communicable diseases 
and through field investigations.
    The surveillance emphasis has shifted as certain diseases have 
declined in incidence, national emergencies have prompted involvement 
in new areas, and other diseases have taken on new aspects. 
Surveillance for the following diseases was approved three years ago: 
Creutzfeldt-Jakob Disease (CJD), Cyclosporiasis cayetanensis, Q Fever, 
Dengue, Reye Syndrome, Hantavirus pulmonary syndrome (HPS), Tick-borne 
Rickettsial Disease, Kawasaki syndrome, Trichinosis, Legionellosis, 
Tularemia, Lyme Disease (LD), Typhoid Fever, Malaria, Viral Hepatitis, 
and Plague. Due to change requests and surveillance systems moving to 
and receiving information collection approval under OMB Control number 
0920-0728 (National Notifiable Diseases Surveillance System (NNDSS)) 
during the last three years, the following diseases/conditions are now 
included in this program: Creutzfeldt-Jakob Disease (CJD), Reye 
Syndrome, Kawasaki syndrome, and Acute Flaccid Myelitis. CDC needs to 
continue this surveillance package for another three years to maintain 
continuity in these surveillance systems. The data throughout the years 
are used to monitor the occurrence of non-notifiable conditions and to 
plan and conduct prevention and control programs at the state, 
territorial, local and national levels.
    CDC currently collects data for certain diseases in summary form 
under OMB Control number 0920-0004, (National Disease Surveillance 
Program II--Disease Summaries). These disease summaries are for 
important, yet different types of infections from those covered in this 
disease case reports request. Maintaining separate OMB Control number 
approvals for these two types of data collections assists CDC in 
managing the two surveillance activities.
    CDC works with state health departments to propose, coordinate, and 
evaluate nationwide surveillance systems. State epidemiologists are 
responsible for the collection, interpretation, and transmission of 
medical and epidemiological information to CDC.
    The original purpose for reporting communicable diseases was to 
determine the prevalence of diseases dangerous to public health. 
However, collecting data also provided the basis for planning and 
evaluating effective programs for prevention and control of infectious 
diseases. Current information on disease incidence is needed to study 
present and emerging disease problems. CDC coordination of nationwide 
reporting maintains uniformity so that comparisons can be made from 
state to state and year to year.
    In addition to development of prevention and control programs, 
surveillance data serves as statistical material for those engaged in 
research or medical practice, aid to health education officials and 
students, and data for manufacturers of pharmaceutical products. Annual 
surveillance data are published in the MMWR Surveillance Summary. The 
total burden requested is 190 hours, a decrease in 11,257 hours since 
the last submission. This is due to the other diseases reporting moving 
to the Notifiable Diseases Surveillance System (0920-0728). There is no 
cost to respondents other than their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                                      Average
                                                                     Number of       Number of      burden per
          Type of respondents                   Form name           respondents    responses per   response (in
                                                                                    respondent         hrs.)
----------------------------------------------------------------------------------------------------------------
Epidemiologist........................  CJD.....................              20               2           20/60
Epidemiologist........................  Kawasaki Syndrome.......              55               8           15/60
Epidemiologist........................  Reye Syndrome...........              50               1           20/60
Epidemiologist........................  Acute Flaccid Myelitis..             100               1           30/60
                                                                 -----------------------------------------------
    Total.............................  ........................  ..............  ..............  ..............
----------------------------------------------------------------------------------------------------------------


Leroy Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2015-31706 Filed 12-16-15; 8:45 am]
BILLING CODE 4163-18-P